{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:32:00Z","timestamp":1783953120916,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.idnow.2024.105007","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T08:33:38Z","timestamp":1730277218000},"page":"105007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) on optimal antimicrobial therapy in gram-negative bloodstream infections"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1468-4960","authenticated-orcid":false,"given":"\u00d6zge","family":"\u00d6zgen Top","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-5063","authenticated-orcid":false,"given":"Beyza","family":"\u00c7ifci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-1374","authenticated-orcid":false,"given":"Merve","family":"B\u00fcy\u00fckk\u00f6r\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8232-1461","authenticated-orcid":false,"given":"Handan","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8737-9110","authenticated-orcid":false,"given":"P\u0131nar","family":"Aysert Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-8539","authenticated-orcid":false,"given":"Halil Furkan","family":"Martl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2215-2756","authenticated-orcid":false,"given":"Elif Ay\u00e7a","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-6453","authenticated-orcid":false,"given":"Kayhan","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3894-0092","authenticated-orcid":false,"given":"Hasan Sel\u00e7uk","family":"\u00d6zger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldz033","article-title":"Gram-negative bloodstream infections and sepsis: risk factors, screening tools and surveillance","volume":"132","author":"Mitchell","year":"2019","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0010","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.03935-14","article-title":"Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis","volume":"59","author":"Cain","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jac\/dkw402","article-title":"Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis","volume":"72","author":"Battle","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12879-023-08329-2","article-title":"Effect of appropriate empirical antimicrobial therapy on mortality of patients with Gram-negative bloodstream infections: a retrospective cohort study","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.idnow.2024.105007_b0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/21505594.2016.1159366","article-title":"Epidemiology of antimicrobial resistance in bloodstream infections","volume":"7","author":"Akova","year":"2016","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.idnow.2024.105007_b0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00134-020-05950-6","article-title":"Bloodstream infections in critically ill patients: an expert statement","volume":"46","author":"Timsit","year":"2020","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.idnow.2024.105007_b0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41579-023-00936-9","article-title":"Antibiotic-induced collateral damage to the microbiota and associated infections","volume":"21","author":"de Nies","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10096-020-04014-3","article-title":"Rapid identification and antimicrobial susceptibility testing of Gram-negative rod on positive blood cultures using MicroScan panels","volume":"40","author":"Infante","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idnow.2024.105007_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.859935","article-title":"Diagnosis and Management of Bloodstream Infections With Rapid, Multiplexed Molecular Assays","volume":"12","author":"Dunbar","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.idnow.2024.105007_b0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkz548","article-title":"The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles","volume":"75","author":"Jonasson","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.idnow.2024.105007_b0055","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/jac\/dkaa333","article-title":"EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories","volume":"75","author":"\u00c5kerlund","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2024.105007_b0060","unstructured":"European Committee on Antimicrobial Susceptibility Testing (EUCAST), European Society of Clinical Microbiology and Infectious Diseases [Internet]. Rapid AST directly from blood culture bottles. 2022 [cited June 5, 2024]. Available at: https:\/\/www.eucast.org\/rapid_ast_in_bloodcultures."},{"issue":"7","key":"10.1016\/j.idnow.2024.105007_b0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/528867","article-title":"Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2024.105007_b0070","unstructured":"EUCAST [Internet]. Methodology - EUCAST rapid antimicrobial susceptibility testing (RAST) directly from positive blood culture bottles. 2023 [cited June 5, 2024]. Available at: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/RAST\/2023\/EUCAST_RAST_methodology_v4.0_final.pdf."},{"key":"10.1016\/j.idnow.2024.105007_b0075","unstructured":"EUCAST [Internet]. Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST. 2024 [cited June 5, 2024]. Available at: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/QC\/v_14.0_EUCAST_QC_tables_routine_and_extended_QC.pdf."},{"key":"10.1016\/j.idnow.2024.105007_b0080","unstructured":"EUCAST [Internet]. Quality control criteria for the implementation of the RAST method. 2023 [cited June 5, 2024]. Available at: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/RAST\/2023\/EUCAST_RAST_QC_v_6.0_final_new.pdf."},{"issue":"12","key":"10.1016\/j.idnow.2024.105007_b0085","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1093\/jac\/dkad332","article-title":"Evaluation of prolonged incubation time of 16\u201320 h with the EUCAST rapid antimicrobial susceptibility disc diffusion testing method","volume":"78","author":"Jonasson","year":"2023","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.idnow.2024.105007_b0090","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jiac.2023.06.016","article-title":"Evaluation of the feasibility of EUCAST RAST using antimicrobial disks available in Japan","volume":"29","author":"Uechi","year":"2023","journal-title":"J Infect Chemother"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0095","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1093\/cid\/ciaa528","article-title":"Randomized trial evaluating clinical impact of RAPid identification and susceptibility testing for gram-negative bacteremia: RAPIDS-GN","volume":"73","author":"Banerjee","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idnow.2024.105007_b0100","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.idnow.2022.09.002","article-title":"Impact of EUCAST rapid antimicrobial susceptibility testing (RAST) on management of Gram-negative bloodstream infection","volume":"52","author":"Cardot Martin","year":"2022","journal-title":"Infect Dis Now"},{"key":"10.1016\/j.idnow.2024.105007_b0105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jgar.2020.05.015","article-title":"Rapid antimicrobial susceptibility of Enterobacteriaceae by disk diffusion directly from blood culture bottles using the EUCAST RAST breakpoints","volume":"22","author":"Martins","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"issue":"4","key":"10.1016\/j.idnow.2024.105007_b0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijmmb.2021.06.008","article-title":"Evaluation of the performance of rapid antibiotic susceptibility test results using the disk diffusion directly from the positive blood culture bottles","volume":"39","author":"Kansak","year":"2021","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"10.1016\/j.idnow.2024.105007_b0115","doi-asserted-by":"crossref","first-page":"e0255921","DOI":"10.1128\/jcm.02559-21","article-title":"Evaluation of the EUCAST rapid antimicrobial susceptibility test for Enterobacterales-containing blood cultures in china","volume":"60","author":"Shan","year":"2022","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.idnow.2024.105007_b0120","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10096-020-03815-w","article-title":"Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles","volume":"39","author":"Soo","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.idnow.2024.105007_b0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/17843286.2023.2197314","article-title":"EUCAST rapid antimicrobial susceptibility testing (RAST) compared to conventional susceptibility testing: implementation and potential added value in a tertiary hospital in Belgium","volume":"78","author":"Strubbe","year":"2023","journal-title":"Acta Clin Belg"},{"issue":"2","key":"10.1016\/j.idnow.2024.105007_b0130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.36519\/idcm.2024.334","article-title":"The impact of reporting the same-day identification and antibiotic susceptibility test results on the treatment of bloodstream infections","volume":"6","author":"Demir","year":"2024","journal-title":"Infect Dis Clin Microbiol"},{"key":"10.1016\/j.idnow.2024.105007_b0135","unstructured":"World Health Organization [Internet]. Antimicrobial resistance surveillance in Europe 2023\u20132021 data. 2023 [cited June 5, 2024]. Available at: https:\/\/www.who.int\/europe\/publications\/i\/item\/9789289058537."},{"issue":"10","key":"10.1016\/j.idnow.2024.105007_b0140","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10096-018-3408-2","article-title":"Meropenem antimicrobial stewardship program: clinical, economic, and antibiotic resistance impact","volume":"38","author":"Garc\u00eda-Rodr\u00edguez","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.idnow.2024.105007_b0150","article-title":"Tractable targets for meropenem-sparing antimicrobial stewardship interventions","volume":"1","author":"Russell","year":"2019","journal-title":"JAC Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.idnow.2024.105007_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dkaa380","article-title":"Implementation of rapid antimicrobial susceptibility testing combined with routine infectious disease bedside consultation in clinical practice (RAST-ID): a prospective single-centre study","volume":"76","author":"Valentin","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.idnow.2024.105007_b0160","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/jac\/dkab026","article-title":"EUCAST rapid antimicrobial susceptibility testing (RAST): analytical performance and impact on patient management","volume":"76","author":"Berinson","year":"2021","journal-title":"J Antimicrob Chemother"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192400174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266699192400174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T01:40:00Z","timestamp":1733449200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266699192400174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S266699192400174X"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2024.105007","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) on optimal antimicrobial therapy in gram-negative bloodstream infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2024.105007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105007"}}